Showing 1 - 3 results of 3 for search 'Oliver Zolk', query time: 0.01s Refine Results
  1. 1
    Safety, Tolerability, and Pharmacokinetics of Filapixant, a Highly Selective P2X3 Receptor Antagonist, in an Ascending-Single-Dose First-in-Human Study

    Safety, Tolerability, and Pharmacokinetics of Filapixant, a Highly Selective P2X3 Receptor Antagonist, in an Ascending-Single-Dose First-in-Human Study by Klaus Francke, Sybille Baumann, Isabella Gashaw, Stefan Klein, Beate Rohde, Oliver Zolk, Oliver M. Fischer, Christian Friedrich

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Pharmacotherapy of psychiatric inpatients with mental and behavioral disorders caused by sedatives or hypnotics (F13): Results from an observational pharmacovigilance program between 2000 and 2017

    Pharmacotherapy of psychiatric inpatients with mental and behavioral disorders caused by sedatives or hypnotics (F13): Results from an observational pharmacovigilance program betwe... by Philipp Pauwels, Beatrice Haack, Sermin Toto, Johanna Seifert, Renate Grohmann, Martin Heinze, Oliver Zolk, Phileas Johannes Proskynitopoulos, Michael Schneider, Timo Greiner

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Anthracycline‐Induced Cardiomyopathy After Nephro‐/Neuroblastoma in Childhood: The Importance of Cardiological Reference Assessment

    Anthracycline‐Induced Cardiomyopathy After Nephro‐/Neuroblastoma in Childhood: The Importance of Cardiological Reference Assessment by Kristina Kleen, Judith Gebauer, Claudia Spix, Lea L. Kronziel, Inke König, Katja Baust, Gabriele Calaminus, Thorsten Simon, Barbara Hero, Oliver Zolk, Norbert Graf, Hashim Abdul‐Khaliq, Thorsten Langer

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: